Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MI078 in Postpartum Depression
NCT07721961Phase 3Recruiting
- Sponsor
- Nanjing Minova Pharmaceutical
- Start
- Jul 2026
- Primary completion
- Dec 2027
- Countries
- 1
01
Overview
A Phase 3 trial of MI078 in postpartum depression (PPD), sponsored by Nanjing Minova Pharmaceutical. Started Jul 2026; status: recruiting.
02
Drugs
MI078
03
Conditions
postpartum depression (PPD)
Beyond the preview
Go deeper on NCT07721961.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07721961.